WallStreetZenWallStreetZen

NYSEMKT: IBIO
Ibio Inc Stock

$2.15+0.04 (+1.9%)
Updated Jul 19, 2024
IBIO Price
$2.15
Fair Value Price
N/A
Market Cap
$18.54M
52 Week Low
$1.02
52 Week High
$15.99
P/E
-0.44x
P/B
0.75x
P/S
301.5x
PEG
N/A
Dividend Yield
N/A
Revenue
$50.00k
Earnings
-$23.16M
Gross Margin
100%
Operating Margin
-46,066%
Profit Margin
-46,324%
Debt to Equity
1.02
Operating Cash Flow
-$19M
Beta
0.28
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IBIO Overview

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. The company is headquartered in New York City, New York and currently employs 7 full-time employees. The firm is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The firm's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The firm is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The firm's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IBIO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IBIO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IBIO is good value based on its book value relative to its share price (0.75x), compared to the US Biotechnology industry average (6.22x)
P/B vs Industry Valuation
IBIO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more IBIO due diligence checks available for Premium users.

Be the first to know about important IBIO news, forecast changes, insider trades & much more!

IBIO News

Valuation

IBIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.44x
Industry
-18.27x
Market
29.62x

IBIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.75x
Industry
6.22x
IBIO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IBIO's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.2M
Profit Margin
0%
IBIO's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
IBIO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$50.2M
Liabilities
$25.3M
Debt to equity
1.02
IBIO's short-term assets ($36.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IBIO's short-term assets ($36.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IBIO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IBIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.7M
Investing
$1.0M
Financing
$5.0M
IBIO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IBIO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IBIO$18.54M+1.90%-0.44x0.75x
APLM$18.62M-9.57%-0.09x0.45x
CANF$18.36M+15.38%-1.50x2.94x
GLYC$18.31M-4.05%-0.49x0.63x
CARA$18.81M-0.86%-0.15x0.63x

Ibio Stock FAQ

What is Ibio's quote symbol?

(NYSEMKT: IBIO) Ibio trades on the NYSEMKT under the ticker symbol IBIO. Ibio stock quotes can also be displayed as NYSEMKT: IBIO.

If you're new to stock investing, here's how to buy Ibio stock.

What is the 52 week high and low for Ibio (NYSEMKT: IBIO)?

(NYSEMKT: IBIO) Ibio's 52-week high was $15.99, and its 52-week low was $1.02. It is currently -86.55% from its 52-week high and 110.58% from its 52-week low.

How much is Ibio stock worth today?

(NYSEMKT: IBIO) Ibio currently has 8,623,676 outstanding shares. With Ibio stock trading at $2.15 per share, the total value of Ibio stock (market capitalization) is $18.54M.

Ibio stock was originally listed at a price of $4,750.00 in Aug 19, 2008. If you had invested in Ibio stock at $4,750.00, your return over the last 15 years would have been -99.95%, for an annualized return of -40.15% (not including any dividends or dividend reinvestments).

How much is Ibio's stock price per share?

(NYSEMKT: IBIO) Ibio stock price per share is $2.15 today (as of Jul 19, 2024).

What is Ibio's Market Cap?

(NYSEMKT: IBIO) Ibio's market cap is $18.54M, as of Jul 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ibio's market cap is calculated by multiplying IBIO's current stock price of $2.15 by IBIO's total outstanding shares of 8,623,676.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.